Eli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct home ...

After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

Lilly on Wednesday said it would sell a version of Zepbound through the telemedicine company Ro. The privately held Ro is one of the long and growing list of telehealth services prescribing and ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...

Eli Lilly, which has been directing patients to various telehealth sites as it sells its blockbuster obesity medication Zepbound, is broadening its reach, announcing a partnership Wednesday with ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Ro partners with Eli Lilly to offer Zepbound, an FDA-approved obesity treatment, at affordable cash-pay prices through an ...

Dec 11 (Reuters) - Telehealth company Ro said on Wednesday it will offer single-dose vials of Eli Lilly's (LLY.N), opens new tab weight-loss drug Zepbound to patients with obesity, becoming the ...

Eli Lilly is partnering with the Flatiron-based telehealth company Ro to sell a cheaper version of its popular weight-loss drug directly to patients. The partnership will expand access to the ...